Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Intermittent Renal Replacement Therapy Using CITRASATE in Critically-ill Patients: A Retrospective Series

NCT05313230 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05313230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05313230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Intermittent Renal Replacement Therapy Using CITRASATE in Critically-ill Patients: A Retrospective Series
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2022
Completion date
June 30, 2022
Enrollment
61 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, chronic kidney infection